Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) HKSE

6.02

+0.09(+1.52%)

Updated at September 08 03:24PM

Currency In HKD

Valuation

Market Cap5.46B
Enterprise Value6.75B
P/E Ratio47.58
PEG Ratio-1.26
Price/Sales Ratio3.34
Price/Book Ratio1.58
Enterprise/Revenue3.38
Enterprise/EBITDA32.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.08

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue5.28B
Revenue/Share3.59
Gross Profit1.76B
EBITDA1.2B
Net Income646.74M
Diluted EPS0.44

Balance Sheet

Total Cash3.06B
Total Cash/Share2.09
Total Debt2.37B
Total Debt/Equity0.19
Current Ratio2.29
Book Value Per Share8.32

Price History

52-Week Change79.7
52-Week High7.26
52-Week Low3.15
Moving Average 50 Days6.18
Moving Average 200 Days4.82

Statistics

Average Volume4.06M
Shares Outstanding3.22B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.9
Payout Ratio0.28
Last Split FactorN/A
Last Split DateN/A